Total Payments
$2,841
2024 Payments
$14.06
Companies
33
Transactions
199
Medicare Patients
1,376
Medicare Billing
$117,731
Payment Breakdown by Category
Food & Beverage$2,778 (97.8%)
Education$62.26 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,778 | 197 | 97.8% |
| Education | $62.26 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $574.68 | 39 | $0 (2023) |
| Lilly USA, LLC | $421.96 | 35 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $245.27 | 22 | $0 (2019) |
| GlaxoSmithKline, LLC. | $176.08 | 12 | $0 (2021) |
| ABBVIE INC. | $166.04 | 11 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $141.60 | 5 | $0 (2021) |
| Amgen Inc. | $130.24 | 10 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $120.34 | 9 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $112.62 | 7 | $0 (2023) |
| Allergan Inc. | $90.83 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.06 | 1 | CVRx, Inc. ($14.06) |
| 2023 | $30.47 | 2 | Novo Nordisk Inc ($15.29) |
| 2022 | $160.25 | 11 | PFIZER INC. ($30.82) |
| 2021 | $416.08 | 17 | Novo Nordisk Inc ($225.24) |
| 2020 | $254.64 | 14 | GlaxoSmithKline, LLC. ($67.51) |
| 2019 | $591.42 | 45 | Lilly USA, LLC ($209.55) |
| 2018 | $869.71 | 73 | Merck Sharp & Dohme Corporation ($131.34) |
| 2017 | $503.94 | 36 | Merck Sharp & Dohme Corporation ($89.58) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: VACCINES | ||||||
| 10/11/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Diabetes | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: Cardiovascular | ||||||
| 07/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 07/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: PRIMARY CARE | ||||||
| 05/31/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: VACCINES | ||||||
| 05/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/21/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $96.28 | General |
| Category: Diabetes | ||||||
| 09/07/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/31/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 08/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 08/19/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: RESPIRATORY | ||||||
| 07/28/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 189 | 286 | $59,998 | $17,226 |
| 2022 | 9 | 527 | 814 | $160,827 | $48,068 |
| 2021 | 10 | 512 | 770 | $155,100 | $47,550 |
| 2020 | 6 | 148 | 167 | $17,038 | $4,886 |
Total Patients
1,376
Total Services
2,037
Medicare Billing
$117,731
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 116 | $19,836 | $6,821 | 34.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 42 | $13,776 | $3,877 | 28.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 31 | 33 | $7,788 | $2,771 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 63 | $13,734 | $2,723 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 29 | 32 | $4,864 | $1,034 | 21.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 131 | 307 | $51,469 | $16,064 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 124 | 189 | $41,202 | $11,957 | 29.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 67 | 73 | $16,948 | $5,725 | 33.8% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 58 | 58 | $18,653 | $5,466 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 61 | 70 | $10,640 | $3,221 | 30.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $5,471 | $1,761 | 32.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 24 | 26 | $4,366 | $1,414 | 32.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 53 | $7,663 | $1,364 | 17.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 20 | 21 | $4,415 | $1,096 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 156 | 256 | $55,808 | $16,114 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 186 | $30,566 | $10,165 | 33.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 58 | 61 | $13,896 | $4,877 | 35.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 45 | 48 | $15,233 | $4,861 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 87 | 106 | $16,112 | $4,392 | 27.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 35 | $8,225 | $2,644 | 32.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $6,301 | $1,937 | 30.7% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 15 | 18 | $2,954 | $1,002 | 33.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 16 | 16 | $3,320 | $843.81 | 25.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 24 | $2,685 | $714.72 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 35 | 36 | $7,848 | $2,056 | 26.2% |
About Dr. Lisa Lanning, DO
Dr. Lisa Lanning, DO is a Family Medicine healthcare provider based in Baker City, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023207784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Lanning, DO has received a total of $2,841 in payments from pharmaceutical and medical device companies, with $14.06 received in 2024. These payments were reported across 199 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,778).
As a Medicare-enrolled provider, Lanning has provided services to 1,376 Medicare beneficiaries, totaling 2,037 services with total Medicare billing of $117,731. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Baker City, OR
- Active Since 10/18/2007
- Last Updated 06/14/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023207784
Products in Payments
- Ozempic (Drug) $238.83
- TRULICITY (Drug) $170.80
- JARDIANCE (Drug) $137.09
- JANUVIA (Drug) $132.28
- SYMBICORT (Drug) $110.53
- TRELEGY ELLIPTA (Drug) $106.39
- ENTRESTO (Drug) $97.44
- RYBELSUS (Drug) $96.28
- XARELTO (Drug) $80.96
- TOUJEO (Drug) $72.71
- Victoza (Drug) $65.04
- Aimovig (Biological) $60.58
- Epclusa (Drug) $57.13
- VRAYLAR (Drug) $56.67
- Tresiba (Drug) $55.74
- Creon (Drug) $54.79
- TRADJENTA (Drug) $50.85
- Edarbi (Drug) $43.65
- LINZESS (Drug) $40.17
- BREO (Drug) $39.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Baker City
Dr. Randy Alanko, M.d, M.D
Family Medicine — Payments: $363.87
Family Medicine $363.87
Mr. Eric Lamb, Md, MD
Family Medicine — Payments: $183.53
Family Medicine $183.53
Logan Frederickson, Do, DO
Family Medicine — Payments: $17.86
Family Medicine $17.86
Mr. J Smithson, Md, MD
Family Medicine
Family Medicine
Jonathan Schott, Md, MD
Family Medicine
Family Medicine
Michael Mcqueen, Md, MD
Family Medicine
Family Medicine